NewAmsterdam Pharma Company N.V. (NAMSW) NASDAQ
20.70
-4.2(-16.87%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.01B |
| Enterprise Value | 3.52B |
| P/E Ratio | -18.05 |
| PEG Ratio | 3.01 |
| Price/Sales Ratio | 164.28 |
| Price/Book Ratio | 5.77 |
| Enterprise/Revenue | 144 |
| Enterprise/EBITDA | -14.02 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -9.43 |
| Operating Margin | -9.54 |
Management Effectiveness
| Return On Assets | -0.29 |
| Return On Equity | -0.3 |
Income Statement
| Revenue | 22.5M |
| Revenue/Share | 0.19 |
| Gross Profit | 22.44M |
| EBITDA | -242.33M |
| Net Income | -203.82M |
| Diluted EPS | -1.75 |
Balance Sheet
| Total Cash | 636.11M |
| Total Cash/Share | 5.25 |
| Total Debt | 23,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 9.76 |
| Book Value Per Share | 5.49 |
Price History
| 52-Week Change | 166.75 |
| 52-Week High | 30.45 |
| 52-Week Low | 7.45 |
| Moving Average 50 Days | 22.52 |
| Moving Average 200 Days | 21.8 |
Statistics
| Average Volume | 1,236 |
| Shares Outstanding | 116.9M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
